Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed1
Terminated1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT04991350Phase 4Terminated
Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
Diabetic Macular EdemaDiabetic RetinopathyMacular Ischemia+1 more
StudychairStart date: 2021-11-26
NCT04674254Phase 4Completed
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression
StudydirectorStart date: 2021-03-30

Research Network

Collaboration Network

9 collaborators·19 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ahmed A Abdel-Kader, MD, PhD

Cairo University

Similar
3 trials

Shared therapeutic areas:

Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionDiabetic Macular Edema+2 more

Worked with same sponsors:

Cairo University
Collaborated on 2 trials
Similarity Score58%

Ayman G Elnahry, MD, PhD

Cairo University

Similar
3 trials

Shared therapeutic areas:

Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionDiabetic Macular Edema+2 more

Worked with same sponsors:

Cairo University
Collaborated on 2 trials
Similarity Score58%

Karim M Abdelaty, MBBCH

National Eye Center

Moderately Similar
1 trials

Shared therapeutic areas:

Diabetic Macular EdemaDiabetic RetinopathyMacular Ischemia+1 more

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score44%

Mohamed A Eldaly, MD, PhD

Cairo University

Moderately Similar
1 trials

Shared therapeutic areas:

Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score34%

Wael A Yussuf, MD, MSc

Cairo University

Moderately Similar
1 trials

Shared therapeutic areas:

Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score34%

Hugo Quiroz-Mercado, MD

Asociación para Evitar la Ceguera en México

Related
8 trials

Shared therapeutic areas:

Diabetic Macular EdemaDiabetic RetinopathyProliferative Diabetic Retinopathy
Similarity Score18%

Chung-May Yang, MD

National Taiwan University Hospital

Related
9 trials

Shared therapeutic areas:

Proliferative Diabetic RetinopathyDiabetic Retinopathy
Similarity Score12%

Pablo Velazquez-Martin, MD

Kodiak Sciences Inc

Related
10 trials

Shared therapeutic areas:

Diabetic Macular EdemaDiabetic Retinopathy
Similarity Score12%

Hamid Ahmadieh, MD

Ophthalmic Research Center of Shaheed Beheshti Medical University

Related
11 trials

Shared therapeutic areas:

Diabetic RetinopathyDiabetic Macular Edema
Similarity Score12%

Thomas A. Ciulla, MD

Midwest Eye Institute

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04991350Phase 4StudyChair

Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema

Diabetic Macular EdemaDiabetic RetinopathyMacular Ischemia+1 more
Terminated
NCT04674254Phase 4StudyDirector

Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy

Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression
Completed

All 2 trials loaded